Literature DB >> 8012352

The murine NF2 homologue encodes a highly conserved merlin protein with alternative forms.

V H Haase1, J A Trofatter, M MacCollin, E Tarttelin, J F Gusella, V Ramesh.   

Abstract

The recently isolated gene for neurofibromatosis type 2 (NF2) encodes a 595 amino acid protein, named merlin, which is related to the cytoskeleton-associated proteins moesin, ezrin and radixin. To identify evolutionarily conserved regions and to provide sequence information necessary for the establishment of a mouse model for NF2, we have determined the cDNA sequence of the mouse NF2 tumor suppressor gene, and mapped it in the mouse genome. Mouse merlin is a 596 amino acid protein, 98% identical to human merlin, but one amino acid longer due to the insertion of a proline residue near the C-terminus. Of the nine amino acid differences between mouse and humans, seven occur in the C-terminal 20% of the protein, far from the protein 4.1 domain that defines this family. Two of the NF2 cDNA clones reveal evidence of alternative splicing events that alter the predicted merlin product, one removing a 45 amino acid segment from the middle section of the protein and the other changing the C-terminus. The existence of several different forms of merlin potentially with different primary roles will complicate the identification of the precise function that must be disrupted to cause the NF2-associated tumors. The mouse NF2 homologue maps to Chr 11, in a region homologous to human Chr 22, but devoid of any mouse mutations which could be models of the human disorder.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012352     DOI: 10.1093/hmg/3.3.407

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  7 in total

1.  Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors.

Authors:  A I McClatchey; I Saotome; K Mercer; D Crowley; J F Gusella; R T Bronson; T Jacks
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

2.  Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.

Authors:  L Goutebroze; E Brault; C Muchardt; J Camonis; G Thomas
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Mutational analysis of patients with neurofibromatosis 2.

Authors:  M MacCollin; V Ramesh; L B Jacoby; D N Louis; M P Rubio; K Pulaski; J A Trofatter; M P Short; C Bove; R Eldridge
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

4.  Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.

Authors:  Kseniya Golovnina; Alexander Blinov; Elena M Akhmametyeva; Leonid V Omelyanchuk; Long-Sheng Chang
Journal:  BMC Evol Biol       Date:  2005-12-02       Impact factor: 3.260

5.  Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization.

Authors:  D R LaJeunesse; B M McCartney; R G Fehon
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

6.  Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family.

Authors:  O Turunen; T Wahlström; A Vaheri
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

Review 7.  Using the neurofibromatosis tumor predisposition syndromes to understand normal nervous system development.

Authors:  Cynthia Garcia; David H Gutmann
Journal:  Scientifica (Cairo)       Date:  2014-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.